查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1372862

生物晶片市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按技术、类型、按应用、最终用户、地区和竞争细分

Biochip Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology, By Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022年，全球生物晶片市场估值达到149.6亿美元，预计在预测期内将呈现令人印象深刻的成长，到2028年将维持14.09%的复合年增长率（CAGR）。生物晶片是微型医疗设备的精心代表设计用于同时执行多个生化反应，显着减少分析所需的时间。这些装置包括精心排列在固体基质上的微测试位点或微阵列。生物晶片有多种形式，包括 DNA、蛋白质、酵素和晶片实验室变体。这些紧凑而强大的设备在设计时考虑到用户友好性，并提供精确的关键见解。它们在储存个人医疗和财务资讯方面特别有用，并且可以用于个人追踪。当植入人体后，生物晶片在监测、分析和调节患者健康和生物过程方面发挥关键作用。此外，它们还对危险识别、确保环境安全和加强决策过程做出了重大贡献。因此，生物晶片在全球范围内的基因诊断、肿瘤学、发炎诊断和分子分析等领域得到了广泛的应用。

主要市场驱动因素

生物晶片在个人化医疗的应用越来越广泛

市场概况
预测期 2024-2028
2022 年市场规模 149.6亿美元
2028 年市场规模 330.4亿美元
2023-2028 年复合年增长率 14.09%
成长最快的细分市场 药物发现与开发
最大的市场 北美洲

生物晶片在即时诊断和分子诊断中发挥着至关重要的作用，推动了对其在个人化医疗中应用的高需求。事实证明，这些晶片在区分正常细胞和癌细胞方面具有无价的价值，可以快速分析整个蛋白质组，以用于基于蛋白质的治疗。此外，它们可以作为可靠的工具，以有限的样本量检测多种生物标记物，为疾病诊断和治疗提供巨大潜力。因此，个人化医疗对生物晶片的需求持续飙升。

技术进步不断增强

随着技术的进步，生物晶片在蛋白质体学中的使用显着增加。随着奈米技术的进步，生物晶片由于其增强的功能、减小的尺寸和更广泛的应用而变得更加有价值。它们现在广泛应用于诊断、研究、药物开发和毒理学研究。这些多功能晶片在基因分型、胜肽、客製化医疗和其他各个领域都有应用，这促进了老牌製造商和年轻企业家的新技术的出现。随着对生物晶片的需求持续增长，市场见证了创新产品和研发资金的激增。

即时检测的需求不断增加

对即时检测 (POC) 测试的需求不断增长，将对诊断和医疗保健领域对生物晶片的需求产生重大积极影响。 POC 测试是指在患者附近进行的诊断测试，通常在床边或门诊环境中进行，无需集中实验室设施即可快速提供结果。生物晶片（也称为微阵列）因其多功能性、高效性以及对小型化、高通量诊断应用的适用性而成为 POC 测试的关键推动者。

POC 测试可以增强医疗保健服务的可近性，特别是在服务不足或无法进入集中实验室的偏远地区。基于生物晶片的 POC 测试是便携式的，可以在资源有限的环境中使用。生物晶片可以分析个别患者的生物标记物，从而可以根据患者独特的基因组成製定个人化的治疗计划，这是现代医学的基石。

由于对更快、更方便和个性化诊断的需求的推动，对 POC 测试的需求不断增长，预计将推动对生物晶片的需求。随着生物晶片技术不断发展并适应新出现的医疗保健挑战，它有望在改变医疗诊断格局和改善全球患者护理方面发挥关键作用。

蛋白质体学和基因体学在癌症研究的应用不断增加

蛋白质体学和基因组学在癌症研究中的日益增多的应用将显着增加对生物晶片的需求，彻底改变癌症的诊断、表征和治疗方式。生物晶片，也称为微阵列，由于能够在一次实验中同时分析数千个基因或蛋白质，因此成为这一领域的强大工具。识别早期癌症检测、预后和治疗反应的可靠生物标记至关重要。生物晶片使研究人员能够快速有效地筛选大量潜在的生物标记物，加速发现具有诊断和治疗意义的新型标记。

生物晶片在药物发现和开发中发挥着至关重要的作用。它们有助于筛选针对癌症相关蛋白质或基因的化合物或治疗剂，帮助识别潜在的候选药物并推进标靶治疗的开发。生物晶片使研究人员能够同时分析多个基因或蛋白质，从而减少综合癌症研究所需的时间和资源，从而提高研究效率。

随着癌症研究范围的扩大以及人们对蛋白质组学和基因组学在理解癌症分子复杂性方面的价值的日益认识，对生物晶片的需求预计将随之增长。随着精准医疗在肿瘤学领域变得越来越普遍，生物晶片将继续在提高我们对癌症生物学的了解以及透过更有针对性和有效的治疗来改善患者治疗效果方面发挥关键作用。

主要市场挑战

生物骇客攻击和隐私问题的可能性很高

生物晶片是一种插入手中的微型设备，透过加快任务速度彻底改变了日常生活。这些尖端晶片具有多种优势，例如无缝访问家庭、健身房和办公室，以及方便地储存紧急联络人、社交媒体资料和电子机票。值得注意的是，瑞典选择将这些微晶片植入手中的人数激增。然而，科学家对与生物晶片相关的潜在资料外洩和骇客攻击漏洞表示担忧。这些晶片能够追踪位置、监控消费习惯，甚至记录驾驶行为，因此容易受到未经授权的存取。此外，体内晶片的存在会带来感染风险，并引发对个人自由的质疑。针对这些担忧，美国最近实施了禁止强制使用生物晶片的法规。预计由于生物骇客风险和隐私问题，市场收入成长可能面临限制。加强安全措施和解决隐私问题对于这项创新产业的可持续成长至关重要。

生物晶片成本高且缺乏认识

生物晶片技术的开发是一个成本高度密集的过程。它需要大量的研究和开发工作以及熟练的开发人员，这最终导致最终产品的成本高昂。生物晶片系统本身由在玻璃表面上精心排列的微型探针组成。这些微型样品需要精确的处理和扫描，这需要使用自动化机器人仪器。实施该技术所需的方法和工具的复杂性和特殊性也导致了其高成本。

由于这些因素，生物晶片的商业用途受到阻碍，主要是由于其生产和实施的高价格。此外，人们对生物晶片缺乏认识，特别是在发展中国家，这进一步限制了预测期内潜在的市场收入成长。

主要市场趋势

越来越多地采用生物晶片来检测过敏

许多人都曾遇到各种类型的过敏，例如食物、花粉等，导致一系列症状，包括发烧、皮肤反应、呕吐、气喘和腹泻。为了解决这些问题，过敏测试领域出现了一种引人注目的新技术，即过敏测试生物晶片。该技术目前正在经历显着增长，并涉及使用包含不同过敏原成分的微阵列。透过利用这些生物晶片，医疗保健专业人员能够在一次测量中研究患者特定的致敏模式，从而提高过敏诊断的准确性和效率。

此外，生物晶片在过敏研究中的潜力促使公司投资于新技术的开发。例如，2021年4月，东丽工业宣布成功开发过敏测试生物晶片，能够从微量血液中检测多种过敏原特异性免疫球蛋白E（IgE）抗体。这项突破性创新为提高过敏测试的精确度和有效性带来了巨大的希望。

越来越多地采用生物晶片来检测和测试过敏原，预计将成为整个预测期内过敏测试市场收入成长的主要推动力。随着越来越多的医疗保健提供者和研究人员认识到这项先进技术所提供的优势，其广泛实施将彻底改变过敏诊断领域，从而改善患者护理和治疗结果。

生物晶片在不同领域的使用不断增加

生物晶片技术广泛应用于微生物学、DNA分析、临床病理学、药理学、直肠学和生物化学等多个领域。正在进行的研究工作将推动生物晶片技术的采用，特别是在医疗保健产业，从而在未来几年进一步扩大其在主流市场的使用。生物晶片技术也应用于序列工程，这将促进全球生物晶片市场的成长，并提高生物晶片解决方案的性能和可扩展性。生物晶片製造商正专注于创新其微型实验室的独特方面，以便能够有效地与生物体一起发挥作用。

生物晶片已成为 DNA 定序技术革命的关键组成部分。此外，它们可能为先进的基因定序解决方案铺平道路。基因定序技术与生物晶片的整合将解决各种生物组织的问题，从而实现稀有细胞、单细胞和红色分子分析。儘管如此，生物晶片技术的持续发展及其不断扩大的通量能力预计将扩大其应用范围，从以人群为中心的临床研究到稀有细菌的检测。製造商正在对用于单细胞分析的生物晶片进行大量投资，这将有助于改进生物晶片及其多功能功能，从而成倍提高性能。

细分市场洞察

类型洞察

全球生物晶片市场分为多种类型，包括DNA晶片、晶片实验室、蛋白质晶片等。其中，晶片实验室预计在预测期内将呈现快速的收入成长率。这可以归因于蛋白质体学、细胞生物学、分子生物学、化学等多种应用对生物晶片的高需求。片上实验室设备具有多种优势，包括成本效率、高并行化、低体积试剂、高可扩展性和高灵敏度。预计这些因素将推动晶片实验室领域的成长。此外，晶片实验室技术在生物医学诊断和分析化学中发挥着至关重要的作用。此外，在晶片实验室中进行的双分子操作可以实现超快速的病毒和细菌检测，这使其对于分子生物学非常有价值。

应用洞察

根据应用，全球生物晶片市场分为药物发现与开发、疾病诊断、基因体学、蛋白质体学、体外诊断等。由于体外诊断（IVD）对生物晶片的需求不断增长，预计体外诊断领域将在预测期内占据重要的收入份额。这包括 DNA 分析、晶片实验室技术、蛋白质微阵列和其他阵列应用等应用。生物晶片还可以用于其他 IVD 解决方案，例如毒物基因组学和高通量筛选。例如，2022 年 1 月，马德里理工大学 (UPM) 和马德里卡洛斯三世大学 (UC3M) 的研究人员开发了一种生物晶片，可以简化实验室环境中体外皮肤和其他多层组织的製造过程。

由于基因组学研究中越来越多地采用生物晶片，预计基因组学领域的收入将在预测期内快速增长。基因组学是一种用于研究生物体基因组的结构和功能的技术。 DNA 微阵列和生物晶片技术的使用产生了大量资料，能够对人类基因组进行详细分析，并推动基因组学研究对这些晶片的需求。

区域洞察

北美在整个预测期内占据市场主导地位，这主要是由于政府透过税收激励措施共同努力促进研发。由于生物技术企业、学术和研究组织的高度集中，以及预计未来生物晶片应用领域的技术进步，该地区预计将保持其工业地位。另一方面，在中国和印度的推动下，亚太地区市场可望实现巨大成长。扩大新技术的使用范围、庞大的患者基础、医疗保健系统的进步以及生物晶片技术的日益利用是影响该地区扩张的关键因素。成熟企业正在将生物晶片生产委託给新兴经济体，旨在降低整体成本。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球生物晶片市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术分类（微阵列与微流体）
    • 按类型（DNA 晶片、晶片实验室、蛋白质晶片、其他）
    • 按应用（药物发现与开发、疾病诊断、基因体学、蛋白质体学、体外诊断等）
    • 按最终用户（医院和诊断中心、学术和研究机构、生物技术和製药公司、其他）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图

第 6 章：北美生物晶片市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术
    • 按类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲生物晶片市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术
    • 按类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太地区生物晶片市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术
    • 按类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲生物晶片市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术
    • 按类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲生物晶片市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术
    • 按类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非生物晶片
    • 沙乌地阿拉伯生物晶片
    • 阿联酋生物晶片

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球生物晶片市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Abbott Laboratories Inc.
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Fluidigm Corporation
    • Thermo Fisher Scientific Inc.
    • PerkinElmer Inc.
    • Illumina Inc.
    • Phalanx Biotech Group Inc.
    • BioMerieux SA
    • Qiagen NV

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 1259

In 2022, the Global Biochip Market reached a valuation of USD 14.96 Billion, and it is poised to demonstrate impressive growth during the forecast period, maintaining an impressive Compound Annual Growth Rate (CAGR) of 14.09% through 2028. Biochips represent miniature medical devices meticulously engineered to perform multiple biochemical reactions simultaneously, significantly reducing the required time for analysis. These devices comprise micro-test sites or microarrays meticulously arranged on a solid substrate. Biochips are available in various forms, encompassing DNA, protein, enzyme, and lab-on-a-chip variants. These compact and potent devices are designed with user-friendliness in mind and offer precise critical insights. They find particular utility in storing personal medical and financial information and can be harnessed for individual tracking. When implanted within the human body, biochips play a pivotal role in monitoring, analyzing, and regulating patient health and biological processes. Furthermore, they contribute significantly to hazard identification, ensuring environmental safety and enhancing decision-making processes. As a result, biochips find wide-ranging applications in fields such as gene diagnostics, oncology, inflammatory diagnosis, and molecular analysis on a global scale.

Key Market Drivers

Growing Use of Biochips in Personalized Medicine

Market Overview
Forecast Period2024-2028
Market Size 2022USD 14.96 Billion
Market Size 2028USD 33.04 Billion
CAGR 2023-202814.09%
Fastest Growing SegmentDrug Discovery & Development
Largest MarketNorth America

Biochips play a crucial role in point-of-care diagnosis and molecular diagnostics, driving high demand for their application in personalized medicine. These chips prove invaluable in distinguishing between normal and cancerous cells, enabling rapid analysis of the entire proteome for protein-based therapeutics. Moreover, they serve as reliable tools for detecting a wide range of biomarkers with limited sample quantities, offering immense potential in disease diagnosis and treatment. Consequently, the demand for biochips in personalized medicine continues to soar.

The use of Biochips in molecular diagnostics and point-of-care diagnosis is expected to create a significant demand for these chips in advancing customized medicine. These innovative chips play a crucial role in accurately identifying and differentiating between healthy and malignant cells' proteins, providing valuable insights for protein-based treatments. One of the key advantages of Biochips is their ability to facilitate a comprehensive study of the complete proteome in a quick and efficient manner. Their high demand in personalized medicine stems from their reliability in identifying a wide range of indicators using a limited number of samples, while also offering the potential for effective diagnosis and treatment of various conditions. With their unique capabilities, Biochips are poised to revolutionize the field of personalized medicine and contribute to the advancement of tailored healthcare solutions.

Increased Technological Advancement

The use of Biochips in proteomics has significantly increased alongside technological advancements. With the progress in nanotechnology, Biochips have become even more valuable due to their enhanced functionality, reduced size, and wider range of applications. They are now extensively utilized in diagnostics, research, medication development, and toxicological studies. These versatile chips find applications in genotyping, peptides, customized medicine, and various other fields, which has fostered the emergence of new technologies by both established manufacturers and young entrepreneurs. As the demand for Biochips continues to grow, the market is witnessing a surge in innovative products and funding for research and development.

Increasing Demand for Point-of-care Testing

The increasing demand for point-of-care (POC) testing is poised to have a significant positive impact on the demand for biochips in the field of diagnostics and healthcare. POC testing refers to diagnostic tests that are conducted near the patient, often at the bedside or in outpatient settings, providing rapid results without the need for centralized laboratory facilities. Biochips, also known as microarrays, are a key enabler of POC testing due to their versatility, efficiency, and suitability for miniaturized, high-throughput diagnostic applications.

POC testing can enhance access to healthcare services, particularly in underserved or remote areas with limited access to centralized laboratories. Biochip-based POC tests are portable and can be used in resource-limited settings. Biochips enable the profiling of individual patient biomarkers, allowing for personalized treatment plans tailored to a patient's unique genetic makeup, which is a cornerstone of modern medicine.

The increasing demand for POC testing, driven by the need for faster, more convenient, and personalized diagnostics, is expected to boost the demand for biochips. As biochip technology continues to evolve and adapt to emerging healthcare challenges, it is poised to play a pivotal role in transforming the landscape of healthcare diagnostics and improving patient care globally.

Increasing Application of Proteomics and Genomics in Cancer Research

The increasing application of proteomics and genomics in cancer research is poised to significantly boost the demand for biochips, revolutionizing the way cancer is diagnosed, characterized, and treated. Biochips, also known as microarrays, serve as powerful tools in this endeavor due to their ability to simultaneously analyze thousands of genes or proteins in a single experiment. Identifying reliable biomarkers for early cancer detection, prognosis, and treatment response is essential. Biochips enable researchers to screen large numbers of potential biomarkers quickly and efficiently, accelerating the discovery of novel markers with diagnostic and therapeutic significance.

Biochips play a vital role in drug discovery and development. They facilitate the screening of compounds or therapeutic agents against cancer-related proteins or genes, helping identify potential drug candidates and advancing the development of targeted therapies. Biochips enhance research efficiency by enabling researchers to analyze multiple genes or proteins simultaneously, reducing the time and resources required for comprehensive cancer studies.

The demand for biochips is expected to grow in tandem with the expanding scope of cancer research and the increasing recognition of the value of proteomics and genomics in understanding the molecular intricacies of cancer. As precision medicine becomes more commonplace in oncology, biochips will continue to play a pivotal role in advancing our knowledge of cancer biology and improving patient outcomes through more targeted and effective treatments.

Key Market Challenges

High Chances of Biohacking and Privacy Concern

Biochips, tiny devices inserted into the hands, have revolutionized daily routines by expediting tasks. These cutting-edge chips offer a multitude of benefits, such as seamless access to homes, gyms, and offices, along with the convenience of storing emergency contacts, social media profiles, and e-tickets. Notably, Sweden has witnessed a surge in individuals opting to have these microchips implanted in their hands. However, scientists have raised concerns regarding potential data breaches and hacking vulnerabilities associated with biochips. These chips have the capability to track locations, monitor spending habits, and even record driving behaviors, making them susceptible to unauthorized access. Moreover, the presence of chips inside the body poses infection risks and raises questions about individual freedom. In response to these concerns, the United States has recently implemented regulations to prohibit the forced usage of biochips. It is anticipated that the market's revenue growth may face constraints due to the risks of biohacking and privacy concerns. The need for enhanced security measures and addressing privacy issues is crucial for the sustainable growth of this innovative industry.

High Cost and Lack of Awareness Regarding Biochips

The development of bio-chip technology is a highly cost-intensive process. It requires extensive research and development efforts, as well as skilled developers, which ultimately contributes to the high cost of the end-product. The biochip system itself consists of microscale probes that are carefully formatted on glass surfaces. These microscale samples require precise handling and scanning, which necessitates the use of automated robotic instruments. The complexity and specificity of the methodologies and tools required for implementing this technology also contribute to its high cost.

Due to these factors, the commercial use of biochips has been hindered, primarily due to the high price associated with their production and implementation. Furthermore, there is a lack of awareness regarding biochips, particularly in developing countries, which further limits the potential market revenue growth during the forecast period.

Key Market Trends

Increasing Adoption of Biochips For Detecting Allergies

Many individuals have encountered various types of allergies, such as food, pollen, and others, resulting in a range of symptoms including fever, skin reactions, vomiting, asthma, and diarrhea. To address these issues, the field of allergy testing has witnessed the emergence of a remarkable new technology known as allergy testing biochips. This technology is currently experiencing significant growth and involves the use of microarrays that contain different allergen components. By utilizing these biochips, healthcare professionals are able to investigate patient-specific sensitization patterns in a single measurement, thus enhancing the accuracy and efficiency of allergy diagnoses.

Furthermore, the potential of biochips in allergy research has prompted companies to invest in the development of new technologies. For example, in April 2021, Toray Industries made an announcement regarding the successful development of allergy testing biochips capable of detecting multiple allergen-specific immunoglobin E (IgE) antibodies from trace amounts of blood. This breakthrough innovation holds tremendous promise for improving the precision and effectiveness of allergy testing.

The increasing adoption of biochips for detecting and testing allergens is expected to be a major driver for revenue growth in the allergy testing market throughout the forecast period. As more healthcare providers and researchers recognize the advantages offered by this advanced technology, its widespread implementation will revolutionize the field of allergy diagnostics, leading to improved patient care and outcomes.

Growing Usage of Biochips in Diverse Areas

Biochip technologies are extensively utilized across a range of fields, including microbiology, DNA analysis, clinical pathology, pharmacology, proctology, and biochemistry, among others. Ongoing research endeavors will drive the adoption of biochip technologies, particularly in the healthcare industry, thus further expanding their usage in the mainstream market in the coming years. Biochip technology is also employed in sequence engineering, which is poised to boost the growth of the global biochip market and enhance the performance and scalability of biochip solutions. Manufacturers of biochips are focusing on innovating distinct aspects of their miniature laboratories that can effectively function with living organisms.

Biochips have emerged as a pivotal component in revolutionizing DNA sequencing technology. Moreover, they are likely to pave the way for advanced gene sequencing solutions. The integration of gene sequencing technology and biochips will address various biological tissues, enabling rare cell, single-cell, and red molecule analysis. Nevertheless, the continuous growth of biochip technology and its expanding throughput capacity are expected to broaden its applications, ranging from population-centric clinical studies to the detection of rare bacteria. Manufacturers are making substantial investments in biochips for single-cell analysis, which will contribute to the improvement of biochips and their versatile functions, consequently enhancing performance exponentially.

Segmental Insights

Type Insights

The global biochip market is categorized into various types, including DNA chip, lab-on-a-chip, protein chip, and others. Among these, lab-on-a-chip is projected to exhibit a rapid revenue growth rate during the forecast period. This can be attributed to the high demand for biochips in diverse applications such as proteomics, cell biology, molecular biology, chemistry, and others. Lab-on-chip devices offer multiple advantages, including cost efficiency, high parallelization, low volume reagents, high expandability, and high sensitivity. These factors are anticipated to drive the growth of the lab-on-chip segment. Moreover, lab-on-chip technology plays a crucial role in biomedical diagnostics and analytical chemistry. Additionally, the bimolecular operations performed in lab-on-chips enable ultra-fast virus and bacteria detection, making it highly valuable for molecular biology.

Application Insights

Based on application, the global biochip market is categorized into Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, In-vitro diagnostics, and Others. The In-vitro diagnostics segment is projected to hold a significant revenue share over the forecast period, driven by the increasing demand for biochips in In-Vitro Diagnostics (IVD). This includes applications such as DNA analysis, lab-on-chip technology, protein microarrays, and other array applications. Biochips also find utility in other IVD solutions like toxio-genomics and High Throughput Screening. For example, in January 2022, researchers from the Universidad Politecnica de Madrid (UPM) and the Universidad Carlos III de Madrid (UC3M) developed a biochip that simplifies the manufacturing process of in-vitro skin and other multilayer tissues in a laboratory setting.

The Genomics segment is expected to witness rapid revenue growth during the forecast period due to the increasing adoption of biochips in genomics research. Genomics is a technique used to study the structure and function of an organism's genome. The use of DNA microarrays and biochip technologies has generated vast amounts of data, enabling detailed analysis of the human genome and driving the demand for these chips in genomics research.

Regional Insights

North America dominates the market throughout the projection period, primarily due to the government's concerted efforts to boost R&D through tax incentives. This region is expected to maintain its industrial position, thanks to its high concentration of biotechnology businesses, academic and research organizations, and projected future technological advancements in Biochip applications. The Asia-Pacific regional market, on the other hand, is poised for tremendous growth, driven by China and India. Expanding access to new technologies, a sizable patient base, advancements in the healthcare system, and the increasing utilization of Biochip technology are key factors influencing the region's expansion. Mature businesses are delegating Biochip production to emerging economies, aiming to reduce overall costs.

Key Market Players

  • Abbott Laboratories Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Fluidigm Corporation
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Illumina Inc.
  • Phalanx Biotech Group Inc.
  • BioMerieux SA
  • Qiagen NV

Report Scope:

In this report, the Global Biochip Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biochip Market, By Technology:

  • Microarray
  • Microfluidics

Biochip Market, By Type:

  • DNA Chips
  • Lab-On-a-Chips
  • Protein Chips
  • Others

Biochip Market, By Application:

  • Drug Discovery & Development
  • Disease Diagnostics
  • Genomics
  • Proteomics
  • In-vitro diagnostics
  • Others

Biochip Market, By End User:

  • Hospitals & Diagnostics Centres
  • Academic & Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • Others

Biochip Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Biochip Market.

Available Customizations:

  • Global Biochip market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biochip Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Microarray v/s Microfluidics)
    • 5.2.2. By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others)
    • 5.2.3. By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, In-vitro diagnostics and Others)
    • 5.2.4. By End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Market Map

6. North America Biochip Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biochip Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Biochip Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Biochip Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Biochip Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biochip Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom Biochip Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Italy Biochip Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. France Biochip Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Biochip Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Biochip Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biochip Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Biochip Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Biochip Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Biochip Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Biochip Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Biochip Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biochip Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Biochip Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Biochip Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Biochip Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biochip Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Biochip Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Biochip Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Products Launches

13. Global Biochip Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Abbott Laboratories Inc.
    • 15.5.2. Agilent Technologies Inc.
    • 15.5.3. Bio-Rad Laboratories Inc.
    • 15.5.4. Fluidigm Corporation
    • 15.5.5. Thermo Fisher Scientific Inc.
    • 15.5.6. PerkinElmer Inc.
    • 15.5.7. Illumina Inc.
    • 15.5.8. Phalanx Biotech Group Inc.
    • 15.5.9. BioMerieux SA
    • 15.5.10. Qiagen NV

16. Strategic Recommendations

17. About Us & Disclaimer